Subsequent APC analyses on HRPT2 mutated parathyroid adenomas with loss of parafibromin expression have shown that APC is uniformly expressed in these tumours, thereby demonstrating a superior specificity which potentially could be of clinical use [31]. This evidence concerns the gene CDC73 and parathyroid gland adenoma.